|
業務類別
|
Biotechnology |
|
業務概覽
|
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. |
| 公司地址
| 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154 |
| 電話號碼
| +1 781 652-4500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.fortressbiotech.com |
| 員工數量
| 78 |
| Mr. David Jin |
Principal Accounting Officer, Chief Financial Officer and Head, Corporate Development; Interim Chief Financial Officer and Chief Operating Officer of Avenue Therapeutics |
美元 427.88K |
28/04/2026 |
| Mr. Michael S. Weiss |
Director and Executive Vice Chairman, Strategic Development |
美元 62.67K |
28/04/2026 |
| Dr. Lindsay A. Rosenwald, M.D. |
Chairman of the Board, President and Chief Executive Officer |
美元 62.67K |
28/04/2026 |
|
|
| Mr. Dov Klein |
Independent Director |
28/04/2026 |
| Dr. Jimmie Harvey, Jr,M.D. |
Independent Director |
28/04/2026 |
| Mr. Malcolm Hoenlein |
Independent Director |
28/04/2026 |
| Mr. Michael S. Weiss |
Director and Executive Vice Chairman, Strategic Development |
28/04/2026 |
| Mr. J. Jay Lobell |
Independent Director |
28/04/2026 |
| Dr. Lindsay A. Rosenwald, M.D. |
Chairman of the Board, President and Chief Executive Officer |
28/04/2026 |
| Mr. Kevin L. Lorenz, J.D. |
Independent Director |
28/04/2026 |
|
|
|
|
